Inventor
KANES STEPHEN JAY
US6 patents
Patents
6 patentsUS11236121B2Feb 1, 2022
Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid
SAGE THERAPEUTICS INC23 citations92
US11554125B2Jan 17, 2023
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC8 citations81
US10940156B2Mar 9, 2021
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC13 citations81
US11884696B2Jan 30, 2024
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid
SAGE THERAPEUTICS INC4 citations72
US12083131B2Sep 10, 2024
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC3 citations70
US12358942B2Jul 15, 2025
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid
SAGE THERAPEUTICS INC0 citations60